SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/14/24 Ads-Tec Energy plc 6-K 3/14/24 2:26K EdgarAgents LLC/FA |
Document/Exhibit Description Pages Size 1: 6-K Report of Foreign Private Issuer HTML 15K 2: EX-99.1 Press Release Dated March 14, 2024 HTML 10K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO SECTION 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2024
Commission file number: 001-41188
ADS-TEC Energy Public Limited Company
(Translation of registrant’s name into English)
10 Earlsfort Terrace
Dublin 2, D02 T380, Ireland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
CONTENTS
Appointment of Andreas Fabritius
On February 1, 2024, the board of directors (the “Board”) of ads-tec Energy PLC (the “Company”) appointed Dr. Andreas Fabritius as a new Class II member of the Board, effective immediately. Dr. Fabritius will also serve as a member of the Audit Committee of the Board beginning in late April.
Dr. Fabritius has served as a Partner at Freshfields Bruckhaus Deringer (“Freshfields”), a leading global law firm, for the past three decades, where he specializes in public and private M&A as well as general corporate law. His clients include German and international companies, banks, financial investors, and government agencies. He studied law and economics in Bonn and Speyer in Germany, at the University of Michigan Law School in the US, and at the European Institute in Italy. In addition to his role at Freshfields, Dr. Fabritius serves as British Honorary Consul in Frankfurt am Main.
There are no arrangements or understandings between Dr. Fabritius and any other person pursuant to which Dr. Fabritius was appointed as a director of the Company. In addition, there is no family relationship between Dr. Fabritius and any director or executive officer of the Company. The Board deems Dr. Fabritius an “independent director” as defined by Nasdaq Rule 5605(a)(2).
Additionally, the Company issued a press release announcing Dr. Fabritius’ appointment to the Board. A copy of that press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
Incorporation by Reference
The information furnished in this Report on Form 6-K is hereby incorporated by reference into the Company’s registration statements on Form F-3 (File No. 333-262281) and Form S-8 (File No. 333-263153).
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Form 6-K includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The Company’s actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believe,” “hope,” “predict,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include the Company’s expectations with respect to future performance and involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside the Company’s control and are difficult to predict. Factors that may cause such differences include but are not limited to risks and uncertainties incorporated by reference under “Risk Factors” in the Company’s Form 20-F (SEC File No. 001-41188) filed with the U.S. Securities and Exchange Commission (the “SEC”) on May 11, 2023 and in the Company’s other filings with the SEC. The Company cautions that the foregoing list of factors is not exclusive. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.
Exhibit No. | Description | |
99.1 | Press Release dated March 14, 2024 |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: March 14, 2024 | ADS-TEC ENERGY PLC | ||
By: | /s/ Wolfgang Breme | ||
Name: | Wolfgang Breme | ||
Title: | Chief Financial Officer |
2
This ‘6-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 3/14/24 | |||
2/1/24 | ||||
5/11/23 | 20-F, 6-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/21/23 Ads-Tec Energy plc POS AM 11:138K EdgarAgents LLC/FA 5/11/23 Ads-Tec Energy plc 20-F 12/31/22 95:11M EdgarAgents LLC/FA 3/01/22 Ads-Tec Energy plc S-8 3/01/22 5:120K EdgarAgents LLC/FA |